Acetylsalicylic acid Completed Phase 4 Trials for Metabolic Syndromes / Cardiovascular Disease (CVD) / Atherosclerosis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00860925PeriOperative ISchemic Evaluation-2 Pilot
NCT00272311Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome